Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster doseResearch Published on 2024-01-202024-09-05 Journal: Clinical and experimental medicine [Category] update2024, [키워드] Anti-S-IgG BNT162b2 vaccine booster ChAdOx1-S vaccine COVID-19 Neutralizing antibodies Omicron BA.1 [DOI] 10.1007/s10238-023-01276-x PMC 바로가기 [Article Type] Research
Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational StudyArticle Published on 2024-01-122024-09-05 Journal: Vaccines [Category] update2024, [키워드] booster Cancer COVID-19 vaccines Efficacy Safety [DOI] 10.3390/vaccines12010076 PMC 바로가기 [Article Type] Article
Predictors of Breakthrough SARS-CoV-2 Infection after VaccinationArticle Published on 2023-12-282024-09-05 Journal: Vaccines [Category] update2024, [키워드] antibody booster breakthrough COVID SARS-CoV-2 serology Vaccine [DOI] 10.3390/vaccines12010036 PMC 바로가기 [Article Type] Article
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinationsImmunology Original Research Published on 2023-12-202024-09-05 Journal: Frontiers in immunology [Category] update2024, [키워드] antibody booster COVID-19 IgG IgG4 Tolerance Vaccine [DOI] 10.3389/fimmu.2023.1309997 PMC 바로가기 [Article Type] Immunology Original Research
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid MalignanciesBrief Report Published on 2023-12-202024-09-05 Journal: Viruses [Category] update2024, [키워드] booster COVID-19 lymphoid malignancies SARS-CoV-2 Vaccine variant [DOI] 10.3390/v16010011 PMC 바로가기 [Article Type] Brief Report
Longitudinal evaluation of two different COVID-19 vaccination strategies in individuals with and without previous SARS-CoV-2 infectionOriginal Article Published on 2023-12-012024-09-05 Journal: Le Infezioni in Medicina [Category] update2024, [키워드] anti-SARS-CoV-2 IgG booster Clinical efficacy Follow-up SARS-CoV-2 infections vaccination [DOI] 10.53854/liim-3104-10 PMC 바로가기 [Article Type] Original Article
Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccinationBrief Report Published on 2023-11-282024-09-05 Journal: Human vaccines & immunotherapeutics [Category] update2024, [키워드] antibodies booster Heterologous mRNA vaccine omicron SARS-CoV-2 viral vectored [DOI] 10.1080/21645515.2023.2283916 PMC 바로가기 [Article Type] Brief Report
Safety and Efficacy of a Third Dose of the BNT162b2 Vaccine in Liver-Transplanted and Healthy AdolescentsHepatology Published on 2023-11-092024-09-05 Journal: Jpgn Reports [Category] update2024, [키워드] Adolescent BNT162b2 booster Coronavirus disease 2019 liver transplant third dose [DOI] 10.1097/PG9.0000000000000373 PMC 바로가기 [Article Type] Hepatology
Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed AdultsMajor Article Published on 2023-11-012024-09-05 Journal: Nanoscale [Category] update2024, [키워드] booster CoronaVac COVID-19 Delta immunogenicity omicron reactogenicity Recombinant protein SCB-2019 Vaccine [DOI] 10.1093/infdis/jiad262 PMC 바로가기 [Article Type] Major Article
Ethno-demographic Disparities in humoral responses to the COVID-19 Vaccine among Healthcare WorkersArticle Published on 2023-09-222024-09-05 Journal: Journal of medical virology [Category] update2024, [키워드] antibodies booster COVID-19 Ethnicity neutralizing antibody pandemic racial disparity SARS-CoV-2 Vaccine virus [DOI] 10.1002/jmv.29067 PMC 바로가기 [Article Type] Article